Utpal Koppikar
CIK: 0001742696
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Koppikar Utpal
Koppikar Utpal (SEC CIK 0001742696) files insider reports with the SEC as Director of INSMED Inc (INSM) and Director of C4 Therapeutics, Inc. (CCCC).
Signal8 holds 4 ownership filings by Koppikar Utpal (1 Form 3, 3 Form 4), filed between Jun 20, 2025 and Oct 20, 2026. Those filings report 3 transactions, from Jun 18, 2025 to Oct 19, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Koppikar Utpal's filings is in BRIDGEWATER, NJ.
Recent filings by Koppikar Utpal
Other insiders filing for INSMED Inc (INSM)
- Hudson Paul, Director
- Brennan David R, Director
- SHAROKY MELVIN MD, Director
- Adsett Roger, Chief Operating Officer
- Flammer Martina M.D., Chief Medical Officer
- Lewis William, Chair and CEO